• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便钙卫蛋白预测炎症性肠病复发的诊断准确性:一项荟萃分析。

Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis.

作者信息

Shi Jin-Tong, Chen Nuo, Xu Jia, Goyal Hemant, Wu Zhi-Qi, Zhang Jie-Xin, Xu Hua-Guo

机构信息

Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.

Division of Gastroenterology, Hepatology & Nutrition, University of Texas Health Sciences Center, Houston, TX 77030, USA.

出版信息

J Clin Med. 2023 Feb 2;12(3):1206. doi: 10.3390/jcm12031206.

DOI:10.3390/jcm12031206
PMID:36769850
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9917450/
Abstract

Fecal calprotectin (FC) levels correlate with the disease activity of inflammatory bowel diseases (IBD); however, the utility of FC in predicting IBD relapse remains to be determined. We aim to evaluate the efficacy of fecal calprotectin in predicting the relapse of inflammatory bowel disease. We searched Pubmed (MEDLINE), Embase, Web of Science, and the Cochrane library databases up to 7 July 2021. Our study estimated the pooled sensitivity and specificity, summary receiver operating characteristic (SROC) curve, and the optimal cut-off value for predicting IBD relapse using a multiple threshold model. A total of 24 prospective studies were included in the meta-analysis. The optimal FC cut-off value was 152 μg/g. The pooled sensitivity and specificity of FC was 0.720 (0.528 to 0.856) and 0.740 (0.618 to 0.834), respectively. FC is a useful, non-invasive, and inexpensive biomarker for the early prediction of IBD relapse. An FC value of 152 μg/g is an ideal threshold to identify patients with a high relapse probability.

摘要

粪便钙卫蛋白(FC)水平与炎症性肠病(IBD)的疾病活动相关;然而,FC在预测IBD复发中的效用仍有待确定。我们旨在评估粪便钙卫蛋白在预测炎症性肠病复发方面的疗效。我们检索了截至2021年7月7日的Pubmed(MEDLINE)、Embase、Web of Science和Cochrane图书馆数据库。我们的研究使用多阈值模型估计了合并敏感性和特异性、汇总接受者操作特征(SROC)曲线以及预测IBD复发的最佳临界值。荟萃分析共纳入24项前瞻性研究。FC的最佳临界值为152μg/g。FC的合并敏感性和特异性分别为0.720(0.528至0.856)和0.740(0.618至0.834)。FC是一种用于早期预测IBD复发的有用、非侵入性且廉价的生物标志物。152μg/g的FC值是识别高复发概率患者的理想阈值。

相似文献

1
Diagnostic Accuracy of Fecal Calprotectin for Predicting Relapse in Inflammatory Bowel Disease: A Meta-Analysis.粪便钙卫蛋白预测炎症性肠病复发的诊断准确性:一项荟萃分析。
J Clin Med. 2023 Feb 2;12(3):1206. doi: 10.3390/jcm12031206.
2
Fecal calprotectin in predicting relapse of inflammatory bowel diseases: a meta-analysis of prospective studies.粪便钙卫蛋白预测炎症性肠病复发:前瞻性研究的荟萃分析。
Inflamm Bowel Dis. 2012 Oct;18(10):1894-9. doi: 10.1002/ibd.22861. Epub 2012 Jan 11.
3
Optimal Range of Fecal Calprotectin for Predicting Mucosal Healing in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.粪便钙卫蛋白预测炎症性肠病患者黏膜愈合的最佳范围:一项系统评价和荟萃分析
Visc Med. 2021 Oct;37(5):338-348. doi: 10.1159/000514196. Epub 2021 Jan 21.
4
Fecal Calprotectin for predicting Relapse and Activity in Patients with Crohn's Disease: A Meta-analysis.粪便钙卫蛋白用于预测克罗恩病患者的复发和活动:一项荟萃分析
Euroasian J Hepatogastroenterol. 2016 Jul-Dec;6(2):116-124. doi: 10.5005/jp-journals-10018-1182. Epub 2016 Dec 1.
5
Meta-analysis: fecal calprotectin for assessment of inflammatory bowel disease activity.荟萃分析:粪便钙卫蛋白用于评估炎症性肠病活动度
Inflamm Bowel Dis. 2014 Aug;20(8):1407-15. doi: 10.1097/MIB.0000000000000057.
6
Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.粪便钙卫蛋白检测在鉴别炎症性和非炎症性肠病中的应用:系统评价和经济评估。
Health Technol Assess. 2013 Nov;17(55):xv-xix, 1-211. doi: 10.3310/hta17550.
7
Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.粪便钙卫蛋白测量可作为炎症性肠病患者短期临床结局和黏膜愈合标志物。
World J Gastroenterol. 2017 Nov 7;23(41):7387-7396. doi: 10.3748/wjg.v23.i41.7387.
8
Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.粪便钙卫蛋白在评估炎症性肠病内镜活动度中的应用:一项诊断准确性的荟萃分析
J Gastrointestin Liver Dis. 2018 Sep;27(3):299-306. doi: 10.15403/jgld.2014.1121.273.pti.
9
Fecal Leukocyte Esterase, an Alternative Biomarker to Fecal Calprotectin in Inflammatory Bowel Disease: A Pilot Series.粪便白细胞酯酶:炎症性肠病中粪便钙卫蛋白的替代生物标志物——一项初步系列研究
Gastro Hep Adv. 2022 Feb 3;1(1):45-51. doi: 10.1016/j.gastha.2021.10.006. eCollection 2022.
10
Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.粪便钙卫蛋白检测对成人和儿童炎症性肠病诊断的有效性和成本效益。
Clin Gastroenterol Hepatol. 2014 Feb;12(2):253-62.e2. doi: 10.1016/j.cgh.2013.06.028. Epub 2013 Jul 21.

引用本文的文献

1
Correlation between intestinal ultrasound and fecal calprotectin with endoscopic severity scores for determining the activity in patients with Crohn's disease.肠道超声及粪便钙卫蛋白与内镜严重程度评分在确定克罗恩病患者疾病活动度中的相关性
Abdom Radiol (NY). 2025 Jul 9. doi: 10.1007/s00261-025-05099-0.
2
New insights into the phenomenon of remissions and relapses in autoimmune diseases and the puzzle of benign autoantibodies in healthy individuals.对自身免疫性疾病缓解和复发现象以及健康个体中良性自身抗体之谜的新见解。
Front Immunol. 2025 May 9;16:1522356. doi: 10.3389/fimmu.2025.1522356. eCollection 2025.
3
Evaluation of Tryptophan and Its Metabolites in Predicting Disease Activation in Inflammatory Bowel Disease.

本文引用的文献

1
Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease.肠道微生物群是炎症性肠病的一种潜在生物标志物。
Front Nutr. 2022 Jan 21;8:818902. doi: 10.3389/fnut.2021.818902. eCollection 2021.
2
Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis.粪便钙卫蛋白在预测溃疡性结肠炎患者黏膜愈合中的临床价值
Front Med (Lausanne). 2021 Aug 3;8:679264. doi: 10.3389/fmed.2021.679264. eCollection 2021.
3
Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study.
色氨酸及其代谢产物在预测炎症性肠病疾病活动中的评估
J Clin Med. 2025 Feb 5;14(3):1016. doi: 10.3390/jcm14031016.
4
The role of intestinal ultrasound with colour Doppler in predicting the response to biologic therapy in inflammatory bowel disease patients.彩色多普勒肠道超声在预测炎症性肠病患者生物治疗反应中的作用。
Prz Gastroenterol. 2024;16(4):416-422. doi: 10.5114/pg.2023.132932. Epub 2023 Nov 17.
5
Efficacy and Safety of Anthocyanin-Rich Extract in Patients with Ulcerative Colitis: A Randomized Controlled Trial.富含花青素提取物治疗溃疡性结肠炎患者的疗效与安全性:一项随机对照试验
Nutrients. 2024 Dec 4;16(23):4197. doi: 10.3390/nu16234197.
6
Serum vascular endothelial growth factor has diagnostic and prognostic significance in ulcerative colitis.血清血管内皮生长因子在溃疡性结肠炎的诊断和预后中有意义。
Turk J Med Sci. 2024 May 17;54(4):718-726. doi: 10.55730/1300-0144.5841. eCollection 2024.
7
Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers.炎症性肠病中的精准医学:聚焦新兴分子生物标志物
Biomedicines. 2024 Jul 8;12(7):1520. doi: 10.3390/biomedicines12071520.
8
Treatment success in cats with chronic enteropathy is associated with a decrease in fecal calprotectin concentrations.患有慢性肠病的猫的治疗成功与粪便钙卫蛋白浓度降低有关。
Front Vet Sci. 2024 Apr 3;11:1390681. doi: 10.3389/fvets.2024.1390681. eCollection 2024.
9
Absolute monocyte counts could predict disease activity and secondary loss of response of patients with Crohn's disease treated with anti-TNF-α drug.绝对单核细胞计数可预测接受抗 TNF-α 药物治疗的克罗恩病患者的疾病活动度和继发性应答丧失。
PLoS One. 2024 Apr 10;19(4):e0301797. doi: 10.1371/journal.pone.0301797. eCollection 2024.
10
Progression of Diabetic Kidney Disease and Gastrointestinal Symptoms in Patients with Type I Diabetes.1型糖尿病患者糖尿病肾病的进展及胃肠道症状
Biomedicines. 2023 Sep 29;11(10):2679. doi: 10.3390/biomedicines11102679.
粪便钙卫蛋白可预测接受生物疗法治疗的溃疡性结肠炎患者的黏膜愈合:一项前瞻性研究。
Clin Transl Gastroenterol. 2020 May;11(5):e00174. doi: 10.14309/ctg.0000000000000174.
4
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab.基线时的血清肿瘤坏死因子-α预测英夫利昔单抗治疗克罗恩病患者的黏膜愈合情况。
Aliment Pharmacol Ther. 2020 Jul;52(2):284-291. doi: 10.1111/apt.15870. Epub 2020 Jun 7.
5
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study.生物标志物界值与克罗恩病内镜结局的关联:CALM 研究的事后分析。
Inflamm Bowel Dis. 2020 Sep 18;26(10):1562-1571. doi: 10.1093/ibd/izaa025.
6
Bedside Optic Nerve Ultrasonography for Diagnosing Increased Intracranial Pressure: A Systematic Review and Meta-analysis.床边视神经超声检查诊断颅内压增高:系统评价和荟萃分析。
Ann Intern Med. 2019 Dec 17;171(12):896-905. doi: 10.7326/M19-0812. Epub 2019 Nov 19.
7
Systematic Review with Meta-Analysis: Fecal Calprotectin as a Surrogate Marker for Predicting Relapse in Adults with Ulcerative Colitis.系统评价与荟萃分析:粪便钙卫蛋白作为预测成人溃疡性结肠炎复发的替代标志物。
Mediators Inflamm. 2019 May 28;2019:2136501. doi: 10.1155/2019/2136501. eCollection 2019.
8
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers.维得利珠单抗在炎症性肠病门诊患者的真实世界治疗中是有效且安全的:一项在初级炎症性肠病中心进行的多中心、观察性研究。
Eur J Intern Med. 2019 Aug;66:85-91. doi: 10.1016/j.ejim.2019.06.006. Epub 2019 Jun 14.
9
Combined evaluation of biomarkers as predictor of maintained remission in Crohn's disease.联合生物标志物评估预测克罗恩病缓解持续状态。
World J Gastroenterol. 2019 May 21;25(19):2354-2364. doi: 10.3748/wjg.v25.i19.2354.
10
Faecal calprotectin in inflammatory bowel diseases: a review focused on meta-analyses and routine usage limitations.炎症性肠病中的粪便钙卫蛋白:一篇侧重于荟萃分析和常规应用局限性的综述。
Clin Chem Lab Med. 2019 Aug 27;57(9):1295-1307. doi: 10.1515/cclm-2018-1063.